AbbVie Receives FDA Approval for RINVOQ

On August 16, AbbVie (ABBV) announced that it received FDA approval of RINVOQ (upadacitinib), a 15 mg, once-daily oral Janus kinase (JAK) inhibitor. The drug is expected to be available in the U.S. by the end of August 2019. RINVOQ treats adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate […]

Read more...

Lockheed Martin Receives $320 Million Contract from US Missile Defense Agency

On August 6, Lockheed Martin (LMT) announced that the company received a  $320 million contract from the US Missile Defense Agency. Lockheed Martin will continue to evolve the Command, Control, Battle Management, and Communications (C2BMC) system that is part of the U.S. Ballistic Missile Defense System. Under this contract, Lockheed Martin will integrate the Long-Range […]

Read more...

July 2019 Scorecard

The July 2019 scorecard for the signals generated from Sonal can be downloaded here. For more information regarding how you can trade these signals, see the article The Three Moves for Event Based Trading Try Sonal 30 days for free and cancel anytime! Subscribe here and check out the Quickstart Guide

Read more...